CELEX: 62018TA0502
Language: en
Date: 2019-09-17 00:00:00
Title: Case T-502/18: Judgment of the General Court of 17 September 2019 — Pharmadom v EUIPO — IRF (MediWell) (EU trade mark — Opposition proceedings — Application for EU figurative mark MediWell — Earlier national word mark WELL AND WELL and earlier national figurative mark well & well LES PHARMACIENS — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

25.11.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 399/51
            
         
      Judgment of the General Court of 17 September 2019 — Pharmadom v EUIPO — IRF (MediWell)
      (Case T-502/18) (1)
      
      (EU trade mark - Opposition proceedings - Application for EU figurative mark MediWell - Earlier national word mark WELL AND WELL and earlier national figurative mark well & well LES PHARMACIENS - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
      (2019/C 399/62)
      Language of the case: English
      
         Parties
      
      
         Applicant: Pharmadom (Boulogne-Billancourt, France) (represented by: M.-P. Dauquaire, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: S. Bonne and H. O’Neill, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO: IRF s. r. o. (Bratislava, Slovakia)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 8 June 2018 (Case R 6/2018-5), relating to opposition proceedings between Pharmadom and IRF.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  
                     Dismisses the action;
                  
               
            
                  2.
               
               
                  
                     Orders Pharmadom to pay the costs.
                  
               
            
         (1)  OJ C 373, 15.10.2018.